News
BWAY
13.74
-0.22%
-0.03
Micron To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Thursday
Benzinga · 18h ago
Brainsway Price Target Cut to $15.00/Share From $30.00 by HC Wainwright & Co.
Dow Jones · 19h ago
Brainsway Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 19h ago
Brainsway price target adjusted to $15 at H.C. Wainwright after ADS ratio change
TipRanks · 20h ago
HC Wainwright & Co. Maintains Buy on BrainsWay, Lowers Price Target to $15
Benzinga · 20h ago
BrainsWay at an all-time high on Q4 beat, upside guidance
Seeking Alpha · 1d ago
Midday Fly By: IEA to release 400M oil barrels, Oracle reports Q3 beat
TipRanks · 1d ago
BrainsWay Reports Q4 Earnings: Revenue Beat, Guidance Below Estimates
Benzinga · 1d ago
BrainsWay Posts Record 2025 Results and Issues Bullish 2026 Outlook on Deep TMS Momentum
TipRanks · 1d ago
Brainsway reports Q4 EPS 7c, consensus 3c
TipRanks · 1d ago
Brainsway sees FY26 revenue $66M-$68M, consensus $64.79M
TipRanks · 1d ago
BrainsWay GAAP EPS of $0.07 beats by $0.04, revenue of $14.55M beats by $0.53M
Seeking Alpha · 1d ago
Earnings Scheduled For March 11, 2026
Benzinga · 1d ago
BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Barchart · 2d ago
Here are the major earnings before the open Wednesday
Seeking Alpha · 2d ago
Pre-Market Earnings Report for March 11, 2026 : CPB, ASM, CXM, TH, RERE, SERV, SNDA, KMDA, BWAY, TSSI, OPFI, SDHC
NASDAQ · 2d ago
Uncovering Potential: BrainsWay's Earnings Preview
Benzinga · 2d ago
Brainsway’s New Deep TMS Depression Study Completion: What Investors Should Watch Next
TipRanks · 2d ago
BrainsWay Q4 2025 Earnings Preview
Seeking Alpha · 2d ago
Weekly Report: what happened at BWAY last week (0302-0306)?
Weekly Report · 3d ago
More
Webull provides a variety of real-time BWAY stock news. You can receive the latest news about Brainsway Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About BWAY
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.